Indo-Asian scenario of microbes, infections, antibiotics and resistance - By Dr. A.J. Tamhankar

-Pathogens that show resistance to antimicrobials: A New medical threat (Philippine Daily Inquirer)
-Centers for Disease Control and Prevention (CDC).Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR. 2009;58:256-260. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5810a4.htm
-NDM 1- interview with two experts from Centers for Disease Control and Prevention (CDC)

Indo-Asian scenario of microbes, infections, antibiotics and resistance - By Dr. A.J. Tamhankar

-"Other than a single brand named `Hitkari Honey`, all Well known brands available in India including one each from Australia and Switzerland were found to contain multiple antibiotics, Says CSE. Read more: The Times of India
-Australian company says no honey contamination (Hindustan Times)
-Indian Firms deny CSE allegations on antibiotics in honey -Urge the CSE “not to create an atmosphere of fear in the name of research”. (The Tribune)
-Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, Indonesia. BMC Infect Dis. 2010 Jul 9;10:203
-Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. J Infect Dev Ctries. 2010 Sep 3;4(8):517-20.

Indo-Asian scenario of microbes, infections, antibiotics and resistance - By Dr. A.J. Tamhankar

-The World Health Organisation’s 63rd Regional Committee Session in Bangkok on Wednesday discussed the drug-resistant “superbug” (NDM1) and called for efforts at the national and international level to preserve the efficacy of antimicrobial agents through the rational use of antibiotics. (Indian Express)
-Japan confirms its first case of new superbug gene
-Japan – nosocomial A baumannii outbreak may have grown

Indo-Asian scenario of microbes, infections, antibiotics and resistance - By Dr. A.J. Tamhankar

-DRUG-RESISTANT bacteria (NDM 1) triggers debate in India. --------Drugs vs Bugs (Indian Express) ----------A team of researchers from Hinduja National Hospital and Medical Research Centre - Payal Deshpande, Camilla Rodrigues, Anjali Shetty, Farhad Kapadia, Ashit Hedge and Rajeev Soman - had in March 2010 published a paper about NDM1 in the Journal of the Association of Physicians of India. The Lancet article, however, did not cite this paper in its issue.-----Dr Shashank Joshi, eminent endocrinologist and editor of JAPI said that scientific theory behind superbugs and drug resistance is fine, but it is preposterous and objectionable to blame New Delhi or India for that."Microbes cannot be named after a city or a country and it is fundamentally wrong to name a microbe as New Delhi metallo-lactamase-1 (NDM-1). We should have objected last year when the British scientists gave the nomenclature," he said."Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for several difficult-to-treat infections in humans, and was discovered in the UK but was not named after Kettering, UK," he said deploring the tendency to blame any country for emergence of superbugs. (In OutLookIndia) -----------'India needs an antibiotics audit' (The Times of India)
-Discovery of a new and dangerous gene that can make bacteria resistant to powerful antibiotics raises alarm bells on the growth of antibiotic-resistant bacteria. (The STAR- Malasia)
-NDM1 story a media-freak-out irrationality, the real solution is to give some calm thought to the serious problems behind the panic- the overuse of antibiotics. (Foreign Policy- USA)
-Drug Resistant Bacteria and the Global Economy (A balanced article in `Current Science`- a scientific journal from India)
-UAE scientists look to frog for superbug cure
-Bangalore-based GangaGen is currently in the process of developing a bacteriophage-based antibiotic potent enough to destroy resitant strains of bacteria.
-NEW DELHI: Health minister Ghulam Nabi Azad pointed to a conflict of interest behind the controversial Lancet report of an “Indian” superbug, saying the research was part funded by pharma major Wyeth that had developed an antibiotic meant to combat high resistance bacterial infections.